SMS Pharmaceuticals Limited

₹505.00As of Sun 8 Nov 2026, 12:00 UTC
NSE:SMSPHARMAHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 16.81%
Div yield 0.08%
ROE 14.88%
Drug Manufacturers (General)
Beta (5Y) 0.21
PE TTM 40.43
TSR TTM 76.92%
Mkt cap ₹47.29B
ROIC 10.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹622
23.16%
(83.04%)
Buy 1|0|1|0|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
7.72
8.64
8.62
8.29
4.01%
8.29%
10.66%
4.12%
Revenue₹B
2.720
2.838
2.939
2.893
8.02%
7.97%
11.74%
4.50%
Peers (US$498.1M)
Cap (US$)
PE
830.4M
27.88x
805.5M
20.75x
Capital
TTM
5Y
10Y
Leveragex
1.032
(0.029)
(0.028)
EBIT/Intx
0.657
0.473
0.433
Own earn%
(36.32)
(107.51)
(120.47)
Sh yield%
47.76
43.88
42.91
Owners
Insiders/Inst%
12.55
22.19
Short interest%
4.30
SBC / revenue%
3.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
17–25
$1 testx
—
Incr. ROIC%
9